Romulo J. Bezerra-Soares
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Editorial: Advancements in P2X7 antagonists: from mechanistic insights to therapeutic applications.
Journal: Frontiers in pharmacology
Published: June 17, 2026
The analgesic and gastroprotective activities of the three fungal extracts and their possible correlation with the inhibition of the P2X7 receptor.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 17, 2024
Joannesia princeps Vell. inhibits purinergic P2Y receptors and presents antinociceptive and anti-inflammatory effects.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 14, 2024
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys.
Journal: Antiviral research
Published: March 22, 2020
New Insights in Purinergic Therapy: Novel Antagonists for Uridine 5'-Triphosphate-Activated P2Y Receptors from Brazilian Flora.
Journal: Journal of medicinal food
Published: December 12, 2018
Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials.
Journal: Current drug targets
Published: November 26, 2018
A new insight into purinergic pharmacology: Three fungal species as natural P2X7R antagonists.
Journal: Phytotherapy research : PTR
Published: July 11, 2018
Brilliant Blue Dyes in Daily Food: How Could Purinergic System Be Affected?
Journal: International journal of food science
Published: May 31, 2016
Correction: An Improved Method for P2X7R Antagonist Screening.
Journal: PloS one
Published: September 01, 2015
The Search for New Agonists to P2X7R for Clinical Use: Tuberculosis as a Possible Target.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: May 18, 2015
Natural Products as a Source for New Anti-Inflammatory and Analgesic Compounds through the Inhibition of Purinergic P2X Receptors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 04, 2013
Last Updated: 09/26/2026